🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In their "Magrolimab" research project, the investigators want to find out ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06-21
Trial ID
NCT05738161
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of magrolim...
Status
Terminated
Location
University of Alabama Birmingham
Start Date
2020-09-09
Trial ID
NCT04313881
Treatments Being Tested
This Phase Ib study is designed to evaluate the safety and pharmacokinetics...
Status
Terminated
Location
UC Davis Comprehensive Cancer Center
Start Date
2019-10-08
Trial ID
NCT03922477
Treatments Being Tested
The primary purpose of the study is to evaluate the preliminary safety and ...
Status
Terminated
Location
Yale University
Start Date
2023-06-27
Trial ID
NCT05835011
Treatments Being Tested
Use of magrolimab in combination with standard intensive chemotherapy ("7+3...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-03-31
Trial ID
NCT05829434
Treatments Being Tested
This phase Ib/II trial identifies the best dose and possible benefits and/o...
Status
Terminated
Location
City of Hope Comprehensive Cancer Center
Start Date
2021-04-06
Trial ID
NCT04541017
The primary objectives of this study are: * To confirm the safety and tole...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2017-09-08
Trial ID
NCT03248479
Treatments Being Tested
The primary objectives of this study are: (Phase 1b) to investigate the saf...
Status
Completed
Location
UCLA
Start Date
2016-11-02
Trial ID
NCT02953782
Treatments Being Tested
The primary objectives of this study are to investigate the safety and tole...
Status
Completed
Location
University of Chicago
Start Date
2018-05-23
Trial ID
NCT03558139
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of Hu5F9-G4 (m...
Status
Withdrawn
Location
UC Irvine Health Cancer Center-Newport
Start Date
2024-03-05
Trial ID
NCT05807126
Treatments Being Tested